Possible MDM2 and TP53 genes involvement in the risk of Developing Therapy-Related Myeloid Neoplasms
Over the last few years, the incidence of therapy-related tumors has increased considerably. This implies a serious problem as they often do not respond to conventional treatments and have a worse...